Verified email-pattern data for Gromit Therapeutics is currently limited. You can still use the company insights and contact sections below.
Gromit Therapeutics is a clinical stage bio-pharmaceutical company, developing disruptive gene therapies for inflammatory and age related diseases across human and animal healthcare.
We own a proprietary platform technology targeting aging, inflammation and senescence, focused at delivering a therapeutic gene that has demonstrated strong clinical efficacy and safety in treating cardiovascular, pulmonary and orthopedic conditions.
An ongoing clinical study enrolled over thirty patients to date, and collected initial evidence of safety and efficacy outcomes, with a follow-up period of over a year. The companion animals enrolled in the studies have exhausted all possible surgical or medical treatments and some were about to be euthanized before successfully treated with Gromit Therapeutics gene therapy. These findings will provide foundation for veterinary drug development and support a number of IND applications for human indications.
We have recently reached an exclusive license agreement with the Icahn School of Medicine at Mount Sinai in New York, NY to a broad patent portfolio related to Sphingolipids metabolizing enzyme (SME) and its therapeutic application in senescence, inflammation and aging. This high value technology has been developed in the lab of Efrat Eliyahu, PhD, Assistant Professor of Genetics and Genomics Sciences at Icahn Mount Sinai, and is addressing acute and chronic inflammatory diseases and related conditions. The therapeutic protein is administered as gene therapy via using adeno-associated-virus mediated delivery. Icahn Mount Sinai will continue to partner with Gromit to support Gromit-funded research and clinical efforts that leverage Icahn Mount Sinai’s extraordinary expertise and facilities.
Our technology is also supported by multiple peer reviewed publications, clinical and scientific collaborations and NIH grants.
Company Details
- Founded
- -
- Address
- Ney York, Ny, Us
- Industry
- Biotechnology Research
- Website
- https://www.gromitx.com/
- Keywords
- biotech, longevity, gene therapy.
- HQ
- Ney York, NY
Gromit Therapeutics Questions
Gromit Therapeutics's website is https://www.gromitx.com/
Gromit Therapeutics's LinkedIn profile is https://www.linkedin.com/company/gromit-therapeutics
Gromit Therapeutics's industry is
Biotechnology Research
Gromit Therapeutics's top competitors are
Amino Therapeutics,
Tonix Pharmaceuticals,
Combangio, Inc.,
Depymed, Inc.,
Espervita Therapeutics,
Phoenix Winsupply,
Viamet Pharmaceuticals,
Cytospar,
Karyopharm Therapeutics Inc.,
Addex Therapeutics.
Gromit Therapeutics's categories are Biotechnology Research
Gromit Therapeutics's founding year is 2021
Explore related pages
Related company profiles:
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.